Search Results for "Genway"
Original Source: GenWay Biotech, Inc
As a leading protein and antibody solutions provider, GenWay has a proprietary technology platform and an international network to provide our clients with solutions and applications for antibodies, recombinant proteins, full-length cDNAs, cell lines and tissue samples. We specialize in recombinant proteins and domain-specific IgY (chicken) antibodies and their applications. GenWay’s technology and expertise make high quality protein antigens that enable production of high quality antibodies. To date,...
Matching Channels
None
Matching News
GenWay Biotech Appoints New Vice President Custom Laboratory Services
SAN DIEGO, May 8, 2013 /PRNewswire-iReach/ -- GenWay Biotech today announced the appointment of Michael Dale as the Company's new Vice President of Custom Laboratory Services. In this role, Mr....
GenWay Biotech Names Dr. Ruben Flores-Saaib Vice President of Custom and Catalog Services
San Diego, CA, March 06, 2013 --(PR.com)-- GenWay Biotech today announced the appointment of Ruben Flores-Saaib, PhD as the Company's new Vice President of Custom and Catalog Services. In this ro...
Clinical study predicting risk of near-term MI and death in CAD patients to be published in JACC
FirstMark, a division of GenWay Biotech that is focused on developing and commercializing noninvasive diagnostic and health monitoring tests for unmet clinical needs, today announced that results from...
FirstMark's Clinical Study for Predicting Near-Term Myocardial Infarction/Death Published in JACC
SAN DIEGO, May 9, 2013 /PRNewswire-iReach/ -- FirstMark, a division of GenWay Biotech that is focused on developing and commercializing noninvasive diagnostic and health monitoring tests for unmet cli...
SAN DIEGO, June 20, 2012 /PRNewswire-iReach/ -- FirstMark, the diagnostic division of GenWay Biotech, Inc., is pleased to announce that the company will be exhibiting and presenting at the San Diego A...
FirstMark Scientific Board of Advisors Meet to Discuss New Clinical Studies for PREvent
SAN DIEGO, July 19, 2012 /PRNewswire-iReach/ -- FirstMark, provider of the groundbreaking cardiovascular blood test PREvent, announced the meeting of the Scientific Advisory Board, held today on Jul...
Matching PubMed Articles
None
